{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:47:32Z","timestamp":1791920852555,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10096-023-04564-2","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T03:02:51Z","timestamp":1676516571000},"page":"413-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The use of TNF-\u03b1 antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review"],"prefix":"10.1007","volume":"42","author":[{"given":"Lucas","family":"Armange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e8le","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Petitgas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Arvieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Piau-Couapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Poubeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Revest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3617-5411","authenticated-orcid":false,"given":"Pierre","family":"Tattevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"issue":"3","key":"4564_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00005792-200205000-00005","volume":"81","author":"SA Shelburne Iii","year":"2002","unstructured":"Shelburne Iii SA, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DM et al (2002) Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore). 81(3):213\u2013227","journal-title":"Medicine (Baltimore)."},{"key":"4564_CR2","unstructured":"European AIDS Clinical Society. EACS. Guidelines for the management of people living with HIV in Europe V.11. 2021. https:\/\/www.eacsociety.org\/media\/guidelines-11.1_final_09-10.pdf Accessed on December 2022"},{"key":"4564_CR3","unstructured":"Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. World Health Organization ; 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240031593 Accessed on December 2022"},{"key":"4564_CR4","unstructured":"Groupe des experts \u00ab\u00a0Prise en charge m\u00e9dicale des personnes infect\u00e9es par le VIH\u00a0\u00bb sous l\u2019\u00e9gide du CNS (Conseil National du Sida), Rapport Morlat ; 2018. https:\/\/cns.sante.fr\/wp-content\/uploads\/2018\/05\/experts-vih_infections.pdf Accessed on December 2022"},{"issue":"10","key":"4564_CR5","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.5588\/ijtld.11.0693","volume":"16","author":"G Breton","year":"2012","unstructured":"Breton G, Bourgarit A, Pavy S, Bonnet D, Martinez V, Duval X et al (2012) Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients. Int J Tuberc Lung Dis. 16(10):1365\u20131370","journal-title":"Int J Tuberc Lung Dis."},{"issue":"15","key":"4564_CR6","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","volume":"24","author":"G Meintjes","year":"2010","unstructured":"Meintjes G, Wilkinson RJ, Morroni C, Pepper DJ, Rebe K, Rangaka MX et al (2010) Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS. 24(15):2381\u20132390","journal-title":"AIDS."},{"issue":"10181","key":"4564_CR7","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","volume":"393","author":"J Furin","year":"2019","unstructured":"Furin J, Cox H, Pai M (2019) Tuberculosis. Lancet 393(10181):1642\u20131656","journal-title":"Lancet"},{"issue":"2","key":"4564_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/cid\/civ841","volume":"62","author":"DC Hsu","year":"2016","unstructured":"Hsu DC, Faldetta KF, Pei L, Sheikh V, Utay NS, Roby G et al (2016) A paradoxical treatment for a paradoxical condition: infliximab use in three cases of mycobacterial IRIS. Clin Infect Dis. 62(2):258\u2013261","journal-title":"Clin Infect Dis."},{"issue":"3","key":"4564_CR9","doi-asserted-by":"publisher","first-page":"e012567","DOI":"10.1136\/bmjopen-2016-012567","volume":"7","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Fan W, Yang G, Xu Z, Wang J, Cheng Q et al (2017) Risk of tuberculosis in patients treated with TNF-\u03b1 antagonists: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 7(3):e012567","journal-title":"BMJ Open."},{"issue":"6","key":"4564_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/cid\/civ978","volume":"62","author":"S Ravimohan","year":"2016","unstructured":"Ravimohan S, Tamuhla N, Nfanyana K, Steenhoff AP, Letlhogile R, Frank I et al (2016) Robust reconstitution of tuberculosis-specific polyfunctional CD4+ T-cell responses and rising systemic interleukin 6 in paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. Clin Infect Dis. 62(6):795\u2013803","journal-title":"Clin Infect Dis."},{"issue":"10","key":"4564_CR11","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1086\/592695","volume":"47","author":"TK Blackmore","year":"2008","unstructured":"Blackmore TK, Manning L, Taylor WJ, Wallis RS (2008) Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis. 47(10):e83\u2013e85","journal-title":"Clin Infect Dis."},{"issue":"3","key":"4564_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0163-4453(03)00077-X","volume":"47","author":"MTM Roberts","year":"2003","unstructured":"Roberts MTM, Mendelson M, Meyer P, Carmichael A, Lever AML (2003) The use of thalidomide in the treatment of intracranial tuberculomas in adults: two case reports. J Infect. 47(3):251\u2013255","journal-title":"J Infect."},{"issue":"10","key":"4564_CR13","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1086\/598504","volume":"48","author":"RS Wallis","year":"2009","unstructured":"Wallis RS, van Vuuren C, Potgieter S (2009) Adalimumab treatment of life-threatening tuberculosis. Clin Infect Dis. 48(10):1429\u20131432","journal-title":"Clin Infect Dis."},{"key":"4564_CR14","first-page":"bcr0920103376","volume":"2011","author":"C O\u2019Dowd","year":"2011","unstructured":"O\u2019Dowd C, Kewin P, Morris J, Cotton M (2011) Tuberculosis complicated by immune reconstitution inflammatory syndrome in a patient on anti-TNF\u03b1 therapy for Crohn\u2019s disease. BMJ Case Rep. 2011:bcr0920103376","journal-title":"BMJ Case Rep."},{"issue":"4","key":"4564_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/RHU.0b013e318258b725","volume":"18","author":"JH Jorge","year":"2012","unstructured":"Jorge JH, Graciela C, Pablo AP, Luis SHJ (2012) A life-threatening central nervous system-tuberculosis inflammatory reaction nonresponsive to corticosteroids and successfully controlled by infliximab in a young patient with a variant of juvenile idiopathic arthritis. J Clin Rheumatol. 18(4):189\u2013191","journal-title":"J Clin Rheumatol."},{"issue":"4","key":"4564_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10156-011-0334-y","volume":"18","author":"HS Lee","year":"2012","unstructured":"Lee HS, Lee Y, Lee SO, Choi SH, Kim YS, Woo JH et al (2012) Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis. J Infect Chemother. 18(4):555\u2013557","journal-title":"J Infect Chemother."},{"issue":"7","key":"4564_CR17","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.clineuro.2012.01.027","volume":"114","author":"SJ Vandecasteele","year":"2012","unstructured":"Vandecasteele SJ, De Vriese AS, Vanhooren GT (2012) Reversion of cerebral artery stenoses due to tuberculomas with TNF-\u03b1 antibodies. Clin Neurol Neurosurg. 114(7):1016\u20131018","journal-title":"Clin Neurol Neurosurg."},{"issue":"16","key":"4564_CR18","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1097\/QAD.0b013e328358daea","volume":"26","author":"AS Brunel","year":"2012","unstructured":"Brunel AS, Reynes J, Tuaillon E, Rubbo PA, Lortholary O, Montes B et al (2012) Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS. AIDS. 26(16):2110\u20132112","journal-title":"AIDS."},{"issue":"2","key":"4564_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/WNF.0b013e318285caa1","volume":"36","author":"P de la Riva","year":"2013","unstructured":"de la Riva P, Urtasun M, Castillo-Trivino T, Camino X, Arruti M, Mondrag\u00f3n E et al (2013) Clinical response to thalidomide in the treatment of intracranial tuberculomas: case report. Clin Neuropharmacol. 36(2):70\u201372","journal-title":"Clin Neuropharmacol."},{"issue":"11","key":"4564_CR20","first-page":"567","volume":"28","author":"C Fourcade","year":"2014","unstructured":"Fourcade C, Mauboussin JM, Lechiche C, Lavigne JP, Sotto A (2014) Thalidomide in the treatment of immune reconstitution inflammatory syndrome in HIV patients with neurological tuberculosis. AIDS. 28(11):567\u2013569","journal-title":"AIDS."},{"issue":"9","key":"4564_CR21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/QAD.0000000000000634","volume":"29","author":"C Richaud","year":"2015","unstructured":"Richaud C, Ghosn J, Amazzough K, Poiree S, Lortholary O (2015) Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDS. AIDS. 29(9):1117\u20131119","journal-title":"AIDS."},{"issue":"3","key":"4564_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5694\/mja14.00716","volume":"202","author":"J Molton","year":"2015","unstructured":"Molton J, Huggan P, Archuleta S (2015) Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction. Med J Aust. 202(3):156\u2013157","journal-title":"Med J Aust."},{"issue":"2","key":"4564_CR23","first-page":"ofy027","volume":"5","author":"N Lwin","year":"2018","unstructured":"Lwin N, Boyle M, Davis JS (2018) Adalimumab for corticosteroid and infliximab-resistant immune reconstitution inflammatory syndrome in the setting of TB\/HIV coinfection. Open Forum. Infect Dis. 5(2):ofy027","journal-title":"Infect Dis."},{"issue":"43","key":"4564_CR24","doi-asserted-by":"publisher","first-page":"e22626","DOI":"10.1097\/MD.0000000000022626","volume":"99","author":"M Santin","year":"2020","unstructured":"Santin M, Escrich C, Maj\u00f2s C, Llaberia M, Grijota MD, Grau I (2020) Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis. Medicine (Baltimore). 99(43):e22626","journal-title":"Medicine (Baltimore)."},{"issue":"5","key":"4564_CR25","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s15010-020-01470-z","volume":"48","author":"D Eshagh","year":"2020","unstructured":"Eshagh D, Benali K, Dossier A, Chauveheid MP, Rouzaud D, Goulenok T et al (2020) Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient. Infection. 48(5):799\u2013802","journal-title":"Infection."}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04564-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-023-04564-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04564-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T06:09:40Z","timestamp":1678342180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-023-04564-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["4564"],"URL":"https:\/\/doi.org\/10.1007\/s10096-023-04564-2","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"19 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}